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Feline infectious peritonitis (FIP) is a globally occurring 
fatal disease caused by feline coronaviruses (FCoVs).1 
FCoV infection is common among cats, particularly in 
catteries, in which up to 100% of cats are infected, but 
only approximately 5–10% develop FIP.2–4 In these cats, 
FIP is caused by mutation of the generally harmless 
FCoV, which is sometimes also called feline enteric coro-
navirus (FECV).5–7 When specific mutations occur, the 
virus can then effectively replicate in macrophages, 
which is considered the key event in the pathogenesis of 
FIP.7,8 The virus replicating in macrophages is sometimes 
called feline infectious peritonitis virus (FIPV). However, 
it is important to realise that FECV and FIPV are only 
two biotypes that are almost identical in their genome 
and thus cannot be differentiated by routine reverse 
transcriptase polymerase chain reaction (RT-PCR). 
Among all cats with FIP, approximately 10% develop 
neurological signs,9,10 which occur as a result of virus-
induced pyogranulomatous meningoencephalitis and 
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Abstract
Objectives The objective of this study was to evaluate the sensitivity and specificity of a real-time reverse transcriptase 
polymerase chain reaction (real-time RT-PCR) detecting feline coronavirus (FCoV) RNA in cerebrospinal fluid (CSF) 
of cats with and without neurological and/or ocular signs for the diagnosis of feline infectious peritonitis (FIP).
Methods This prospective case-control study included 34 cats. Nineteen cats had a definitive histopathological 
diagnosis of FIP (seven of these with neurological and/or ocular signs), and 15 cats had other diseases but similar 
clinical signs (three of these with neurological and/or ocular signs). Real-time RT-PCR was performed on the CSF of 
all cats, and sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were calculated.
Results Real-time RT-PCR of CSF showed a specificity of 100% in diagnosing FIP, a sensitivity of 42.1%, a PPV of 
100% and an NPV of 57.7%. The sensitivity of the real-time RT-PCR of CSF in cats with neurological and/or ocular 
signs was 85.7%.
Conclusions and relevance Although it is known that RT-PCR can give false positive results, especially if performed 
using serum or plasma, this real-time RT-PCR detecting FCoV RNA in CSF can be considered a reliable specific 
tool for the diagnosis of FIP. If only cats with neurological involvement are evaluated, the sensitivity of this real-time 
RT-PCR in CSF is also high.
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meningomyelitis.10,11 Commonly reported neurological 
clinical signs are ataxia, seizures, nystagmus, hyperaes-
thesia and cranial nerve deficits.12–15 Most often, a multi-
focal location is suggested, but, occasionally, focal signs 
can also occur.13,16 Ocular manifestations consist pre-
dominantly of uveitis and chorioretinitis with associated 
fibrinous exudate in the anterior ocular chamber, which 
are common in neurological forms of FIP.11,17
The median survival time of cats with FIP is 9 days,18 
and the diagnosis of FIP usually leads to euthanasia. 
Therefore, a reliable diagnostic tool is needed to confirm 
the diagnosis. A definitive diagnosis of FIP remains chal-
lenging, especially if no effusion is present, and requires 
histological examination of biopsy specimens of affected 
organs,3 but this approach is limited in cats with FIP 
restricted to the central nervous system (CNS). RT-PCR 
on blood samples is sometimes used to support a diag-
nosis of FIP; however, both sensitivity and specificity are 
too low to allow a definitive diagnosis or to rule out 
FIP.3,19,20 So far, there has been only one study that looked 
into the diagnostic value of RT-PCR detecting FCoV in 
cerebrospinal fluid (CSF).15
The aim of the present study was to determine sensi-
tivity and specificity of a real-time RT-PCR in CSF to 
diagnose FIP in cats with and without neurological and/
or ocular signs, comparing cats with confirmed FIP with 




This study was designed as a case-control study, and 
included 34 cats. The cats were presented to the Clinic of 
Small Animal Internal Medicine, LMU University of 
Munich, Germany (n = 28), or to private veterinarians 
(n = 6). The FIP group (n = 19) consisted of animals with 
a definitive diagnosis of FIP (Table 1). FIP diagnosis was 
established in all 19 cats by post-mortem examination, 
including full body necropsy with histopathological 
examination. FIP diagnosis was confirmed by typical 
Table 1 Cats with feline infectious peritonitis (FIP), clinical signs, method of confirmation of the diagnosis of FIP, presence 
of neurological and/or ocular signs, and threshold cycle (Ct) values of the tested cerebrospinal fluid (CSF) sample





1 Thoracic effusion, icterus FIP Post mortem Histopathology Seizures No Ct
2 Thoracic effusion, fever FIP Post mortem Histopathology – 36.1 (positive)
3 Thoracic effusion FIP Post mortem Histopathology – No Ct
4 Ascites, icterus, 
neurological signs
FIP Post mortem Histopathology Seizures 32.1 (positive)
5 Ascites, icterus FIP Post mortem Histopathology – No Ct
6 Thoracic effusion FIP Post mortem Histopathology – No Ct
7 Ascites FIP Post mortem Histopathology – No Ct
8 Thoracic and pericardial 
effusions
FIP Post mortem Histopathology – 31.7 (positive)
9 Ascites, neurological 
signs
FIP Post mortem Histopathology Paresis, ataxia, 
anisocoria, inability 
to control urination 
and defecation
32.6 (positive)
10 Ascites, fever, icterus, 
neurological and ocular 
signs
FIP Post mortem Histopathology Paresis, uveitis 32.0 (positive)
11 Ascites, icterus FIP Post mortem Histopathology – No Ct
12 Ascites, icterus FIP Post mortem Histopathology – No Ct
13 Ascites, icterus FIP Post mortem Histopathology – No Ct
14 Thoracic effusion and 
ascites, fever
FIP Post mortem Histopathology – No Ct
15 Fever, icterus, 
neurological signs
FIP Post mortem Histopathology Ataxia 26.5 (positive)
16 Fever, ocular signs FIP Post mortem Histopathology Uveitis 32.0 (positive)
17 Thoracic effusion, fever, 
ocular signs
FIP Post mortem Histopathology Uveitis 29.9 (positive)
18 Thoracic effusion and 
ascites, fever
FIP Post mortem Histopathology – No Ct
19 Ascites, fever, icterus FIP Post mortem Histopathology – No Ct
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morphology (surface-bound multisystemic pyogranu-
lomatous and fibrinonecrotic disease with venulitis with 
or without high-protein exudate). In the control group (n 
= 15), cats for which FIP was considered as a differential 
diagnosis because of ‘FIP typical’ clinical signs were 
included. Cats with one or more of the following clinical 
signs were included: effusion (n = 11), a rectal tempera-
ture of ⩾40°C (with ⩽20,000 white blood cells/µl and 
⩽1000 banded neutrophils/µl; n = 1), icterus (n = 3) or 
neurological signs (n = 3). Cats were only included in 
the control group if they were definitively diagnosed 
with diseases other than FIP that explained the clinical 
signs. These other diseases were confirmed either at nec-
ropsy (n = 13) or ante-mortem (n = 2). One of the two 
cats diagnosed ante-mortem had effusion caused by 
lymphoma, which was confirmed by cytological exami-
nation of thoracic effusion and fine-needle aspiration of 
lymph nodes. The other cat had thoracic effusions caused 
by a decompensated cardiac disease confirmed by echo-
cardiography (Table 2).
Of the 19 cats with FIP, seven had neurological 
(n = 5) and/or ocular (n = 3) signs (Table 1). Of the 15 
cats with other diseases, three had neurological (n = 3) 
and/or ocular (n = 0) signs (Table 2).
Samples
CSF was collected immediately after cats were eutha-
nased with a 19 G needle from the cerebellomedullary 
cistern. Cell-free CSF was stored at –80°C in a 1.5 ml 
Eppendorf Safe-Lock microcentrifuge tube.
Table 2 Cats in the control group with signs for inclusion, confirmed diseases, method of confirmation, presence of 
neurological and/or ocular signs, and the threshold cycle (Ct) values of the tested cerebrospinal fluid (CSF) sample
Cat Signs for 
inclusion








Lymphoma Ante-mortem Cytology – No Ct
2 Ascites Lymphoma Post mortem Necropsy – No Ct
3 Ascites Lymphoma Post mortem Necropsy – No Ct
4 Thoracic 
effusion
Lymphoma Post mortem Necropsy – No Ct
5 Ascites Neoplasia close to 
the liver, probably 
adenocarcinoma  
of the biliary tract

























Pulmonary fibrosis with 
thoracic effusion





Post mortem Necropsy – No Ct
12 Icterus Lymphoma Post mortem Necropsy – No Ct







(interstitially) in the 
lumbar part of the 
spine










due to severe 
hepatolipidosis
Post mortem Necropsy Status 
epilepticus
No Ct
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RNA extraction
Viral RNA was isolated from cell-free CSF using a 
QIAamp Viral Mini RNA Kit (Qiagen). Briefly, 140 µl ali-
quots of samples were lysed under highly denaturing 
conditions to inactivate RNases and isolate the intact 
viral RNA. Adjusted buffering conditions yielded an 
optimal binding of the viral RNA on the silica membrane 
of the QIAamp Mini spin column. After being washed 
with two wash buffers, the RNA was eluted with 60 µl of 
RNase-free buffer and stored at –80°C.
Real-time RT-PCR
The detection of FCoV was performed using a real-time 
RT-PCR.21 A QuantiTect Probe RT-PCR Kit (Qiagen) was 
used for this one-step real-time RT-PCR. Five microlitres 
of RNA template was added to 12.5 µl Master Mix, 0.25 µl 
RT Mix, 5.25 µl RNase-free water and 2 µl primer probe 
mix. All primers were used in a concentration of 0.8 µM, 
and 5’FAM/3’BHQ-1 labelled TaqMan probes were used 
in a concentration of 0.3 µM. The following temperature 
profile was chosen: reverse transcription at 50°C for 30 
mins, reverse transcriptase inactivation and polymerase 
activation at 95°C for 15 mins, 42 cycles of denaturation 
for 30 s at 95°C, and annealing and elongation for 60 s at 
60°C. A Stratagene Mx3005P (Thermo Scientific) was 
used for the fluorescence measurement.
Data analyses
The sensitivity and specificity, as well as the positive (PPV) 
and negative predictive values (NPV), were calculated for 
the whole group, as well as only for cats with neurological 
and/or ocular signs. Ninety-five percent confidence inter-
vals were determined. Data analyses were performed 
using a two-sided Fisher’s exact test with GraphPad Prism 
Version 5.0 and a significance threshold of 0.05.
Results
Results of the real-time RT-PCR in cats with neurological 
and/or ocular signs, and all cats are shown in Table 3. 
Threshold cycle (Ct) values of all real-time RT-PCR results 
are shown in Tables 1 and 2. Sensitivity, specificity, and 
PPV and NPV of real-time RT-PCR of CSF are shown in 
Table 4. None of the specimens were false positive in the 
real-time RT-PCR of CSF, leading to a specificity of 100%. 
Sensitivity was only 42.1% when looking at all cats, but 
was better when the results of only cats with neurological 
and/or ocular signs were evaluated (Table 4).
Discussion
The purpose of this study was to determine sensitivity 
and specificity of a real-time RT-PCR on CSF samples in 
order to assess the diagnostic feasibility of this method 
for the ante-mortem diagnosis of FIP.
Table 3 Results of real-time reverse transcriptase polymerase chain reaction (RT-PCR) of cerebrospinal fluid of all cats 
with feline infectious peritonitis (FIP) and of all cats with other diseases, and of cats with FIP and other diseases with and 
without neurological and ocular involvement
Real-time RT-PCR positive Real-time RT-PCR negative Total
Cats with FIP (n = 19) 8 11 19
Cats with neurological and/or ocular signs (n = 7) 6  1  7
Cats without neurological and without ocular signs 
(n = 12)
2* 10 12
Cats with other diseases (n = 15) 0 15 15
Cats with neurological and/or ocular signs (n = 3) 0  3  3
Cats without neurological and without ocular signs 
(n = 12)
0 12 12
Total 8 26 34
*Post-mortem examination identified microscopic involvement of the central nervous system in one of these cats
Table 4 Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) of real-time reverse 
transcriptase polymerase chain reaction (RT-PCR) in cerebrospinal fluid to diagnose feline infectious peritonitis (FIP)  
and the prevalence of FIP
All cats (n = 34) Cats with neurological and/or ocular signs (n = 10)
Sensitivity 42.1 (20.3–66.5) 85.7 (42.1–99.6)
Specificity 100.0 (78.2–100.0) 100.0 (29.2–100.0)
PPV 100.0 (63.1–100.0) 100.0 (54.1–100.0)
NPV 57.7 (36.9–76.7) 75.0 (19.4–99.4)
Prevalence (%) 55.9 70.0
Values are given as % (95% confidence interval) unless otherwise indicated
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FCoV can be detected in the CSF if the virus replicates in 
CSF macrophages in cats with FIP with neurological 
involvement, or if a spillover of infected blood monocytes 
occurred during the disease or the tap. The entry route for 
FCoV into the CSF is unknown but the virus probably tres-
passes the blood–brain barrier (BBB) cell-bound within 
macrophages. As in other parts of the body, macrophages 
also resemble the principal target cells for FCoV in the 
CNS.17 The other possibility for the presence of FCoV in the 
CNS, and therefore in CSF, is a non-targeted way through 
an impaired BBB or blood–CSF barrier that could be dis-
rupted non-specifically during virtually any inflammation 
of the CNS.22 Generally, in inflammatory states involving 
the CNS, mononuclear cells can enter both by opened tight 
junctions between endothelial cells and via diapedesis 
through endothelial cells.23–26 Even if not specifically inves-
tigated in FIP, the brain endothelium produces inflamma-
tory mediators, adhesion molecules and matrix 
metalloproteinases, which lead to a disruption of the tight 
junction complex allowing particles to cross the barriers.22
The specificity of the real-time RT-PCR in CSF in this 
study was 100%. While RT-PCR is commonly used in 
serum and plasma for the diagnosis of FIP, it is not a relia-
ble tool for confirmation because specificities range only 
between 20% and 90%.3,19,27–29 False positive RT-PCR 
results in serum and plasma can be caused by the fact that 
intestinal infection with harmless FCoV is accompanied by 
viraemia.30,31 Recent studies determined mutations in dif-
ferent parts of the FCoV genome.32,33 Detecting mutations 
in the putative fusion peptide of the spike protein of FCoV 
seems to be a more reliable tool for the diagnosis of FIP,32 
but large studies confirming specificity are still missing. 
The reason for the high specificity of the real-time RT-PCR 
used in the present study, which did not specifically detect 
the mutated virus, can be explained by an absence of FCoV 
in CSF if no inflammation and an intact BBB are present, 
and FCoV is not produced within the CNS. The presence 
of viral RNA therefore seems to be more reliable in diag-
nosing FIP than the presence of antibodies; in a previous 
study anti-coronavirus antibodies were detected in CSF of 
cats with FIP without neurological involvement, but also 
in the CSF of cats with neurological diseases other than 
FIP.34 In this previous study it was postulated that the anti-
coronavirus antibodies were derived from antibody-con-
taining blood and did not necessarily indicate intrathecal 
antibody production and the presence of FCoV in the CNS. 
As many cats are FCoV antibody-positive in blood,2,35 anti-
bodies can easily cross the BBB in cats with any disruption 
of the BBB due to various diseases that impair the BBB or 
CSF flow. Thus, a method, like RT-PCR, detecting the path-
ogen itself instead of antibodies in CSF seems to be more 
specific. The results of the present study are in accordance 
with the only previous study that investigated RT-PCR in 
CSF. In this previous study, similar to the present one, only 
three cats with neurological disease other than FIP were 
investigated,15 but the present study included a large num-
ber of non-neurological controls.
While the real-time RT-PCR in CSF in this study 
showed an excellent specificity, sensitivity was not as 
high (42.1%). Failure to detect FCoV in CSF in this real-
time RT-PCR was most likely caused by the absence of 
CNS inflammation and FCoV-infected macrophages in 
the CSF. In the cats with neurological signs in which 
FCoV was detected in the CSF, Ct values were relatively 
high (mean Ct 30.8; range 26.5–32.6). This indicates that 
the FCoV numbers were relatively low, even if the CNS 
is involved. Nevertheless, the sensitivity of real-time 
RT-PCR in CSF, even when looking at all cats (with and 
without neurological involvement), was even higher in 
the present study than in a previous study with a sensi-
tivity of 31% in cats with neurological involvement.15
In the present study, two cats with FIP with ocular but 
without neurological signs had detectable virus. As ocular 
signs often co-occur with neurological FIP,11,17 these two 
cats could have had the beginning of neurological involve-
ment, without clinical signs and pathological lesions. As 
the CNS and eyes are in close proximity to each other, a 
spillover of infected monocytes into CSF or monocyte 
homing might also be possible. Another two cats with FIP 
but without clinically obvious neurological or ocular signs 
had positive results in real-time RT-PCR in CSF. In one of 
these two cats, histological examination of the brain 
showed inflammatory infiltration with macrophages, 
granulocytes, plasma cells and lymphocytes, as well as 
necrotic lesions, which were obviously too mild to cause 
clinical signs. In the other cat, no visible gross or histologi-
cal lesions were found in the CNS. However, it might be 
that this cat also had the beginnings of neurological 
involvement of FIP without visible changes of tissue.
One limitation of this study was the relatively low 
sample size, especially of cats with neurological and/
or ocular involvement. Another limitation was the 
assignment of cats to the control group. Cats were 
assigned to the control group if a disease other than 
FIP was confirmed that explained the observed signs. 
There is a low probability that a cat in the control group 
suffered from both another disease as well as FIP; how-
ever, this situation was not likely as 13/15 cats were 
examined at necropsy and no false positive real-time 
RT-PCR result was observed in the present study.
Conclusions
This study evaluated the sensitivity and specificity of a 
real-time RT-PCR detecting FCoV in CSF to diagnose FIP 
in cats with and without neurological involvement. The 
study found an excellent specificity, indicating that real-
time RT-PCR in CSF is a reliable tool for diagnosing FIP. 
The sensitivity of this approach was fairly high, at least in 
cats with neurological and/or ocular signs, making this 
an interesting tool for the diagnosis of neurological FIP.
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